Friedrich G, Haas R, Metz G
Arch Int Pharmacodyn Ther. 1984 Feb;267(2):264-8.
Cloxacepride, a potent inhibitor of passive cutaneous anaphylaxis (PCA) in the rat, was evaluated for in vitro inhibitory effect on 48/80-induced histamine and serotonin release from rat mesenterial mast cells. Significant inhibition and linearity of concentration and effect was found in the concentration range of 10 to 50 microM. The IC50 was determined to 21 microM (histamine) and 19 microM (serotonin). A simultaneous liberation of both mediators from mast cells is indicated from nearly identical IC50. LDH increase in the supernatant of the incubation mixture by cell damage resulted from higher concentrations of cloxacepride (greater than 50 microM). The high concentration of 10 micrograms/ml releaser 48/80 did not affect or diminish the effect of cloxacepride, while the reference compounds cromolyn sodium (DSCG) and theophylline were inactive under these conditions. The substantial inhibition of the PCA reaction and of the mediator release from mast cells provides cloxacepride a promising potential antiallergic drug.
氯沙必利是一种对大鼠被动皮肤过敏反应(PCA)有强效抑制作用的药物,本研究评估了其对48/80诱导的大鼠肠系膜肥大细胞组胺和5-羟色胺释放的体外抑制作用。在10至50微摩尔浓度范围内发现了显著的抑制作用以及浓度与效应的线性关系。组胺的半数抑制浓度(IC50)为21微摩尔,5-羟色胺的IC50为19微摩尔。几乎相同的IC50表明肥大细胞可同时释放这两种介质。较高浓度的氯沙必利(大于50微摩尔)会因细胞损伤导致孵育混合物上清液中乳酸脱氢酶(LDH)增加。10微克/毫升的高浓度释放剂48/80不会影响或减弱氯沙必利的作用,而在这些条件下,参考化合物色甘酸钠(DSCG)和茶碱无活性。氯沙必利对PCA反应和肥大细胞介质释放的显著抑制作用使其成为一种有前景的潜在抗过敏药物。